News
Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...
Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...
Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...
As such, Novo Nordisk ended its collaboration with Hims & Hers over concerns of illegal mass compounding and deceptive ...
In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's ...
Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments ...
This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth ...
7d
Pharmaceutical Technology on MSNHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plugNovo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results